Central administration of 6-hydroxydopamine (6OHDA) to newborn rats induced a dose-dependent and long-lasting decrease in noradrenaline (NA) and dopamine (DA) content in adult male and female rat brain. After postnatal administration of 100 µ g 6OHDA, a decrease of about 50% of NA and DA content of the whole brain was found in 9- to 10-week-old rats; 200 µ g 6OHDA induced a reduction of 80 % of NA and DA content. The latter treatment was followed by a severe growth retardation, a marked myosis, a decrease in general activity, and disappearance of clonic convulsions after decapitation. At the same time, however, in both groups of animals no change in basal pituitary-adrenal activity was found, as evaluated by measurement of corticosterone in plasma, in vitro adrenal corticoid production, and adrenal weight. Apparently even severe inhibition of the development of central DA and NA systems by 6OHDA administration to the newborn rat did not induce any change in basal pituitary-adrenal functioning.

Keywords:
Catecholamines, ACTH, 6-Hydroxydopamine (6OHDA), Neonatal
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.